![\"\"](\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/03\/ltat-dividend_20260312201542_pe73h5.jpg\")
<\/a><\/p>\n\u201cBy 2030, our goal is to reduce strategic assets to about 35%,\u201d Ashraf said.<\/p>\n
Overall in 2025, LTAT generated total investment income of RM749.49 million, with real assets contributing the largest share at 38%, or RM286.5 million. Strategic assets provided income of RM140.2 million and public equities RM139.9 million.\u00a0<\/p>\n
Under the transformation plan, LTAT intends to optimise and rebalance its portfolio through selective divestments and reinvestments, allowing capital to be redeployed into sectors with stronger long-term growth prospects and strategic relevance.<\/p>\n
Ashraf said the fund may undertake transactions involving some of its strategic holdings as part of the restructuring process, although details have yet to be finalised.<\/p>\n
\u201cWe need to go through the various processes for each identified one, but the idea is we will do it [on] a structured basis,\u201d he stressed.<\/p>\n
LTAT currently has total assets under management of RM13.36 billion, down 2% year-on-year, mainly due to net withdrawals and the absence of dividend income from Affin Bank Bhd (KL:AFFIN<\/a>), one of the fund\u2019s main investments.<\/p>\n The fund is the third-largest shareholder of Affin Bank, the country\u2019s second-smallest banking group by assets, with about a 22% stake, or 535.35 million shares, as of Feb 24.<\/p>\n LTAT also has an indirect and direct stake of 43.9% in Pharmaniaga Bhd (KL:PHARMA<\/a>), which is showing what Ashraf described as \u201cencouraging signs of recovery\u201d and on track to exit Practice Note 17, a status for financially distressed firms, in the near term.<\/p>\n In total, LTAT declared a dividend of 5.35% for FY2025, its highest payout in eight years, amounting to a total distribution of RM524.74 million to contributors. The fund also saw its reserve fund increase to RM1.3 billion, compared with RM1 billion in 2024.<\/p>\n